The Mixed Modality (Peptide Upstream) Scientist joins Lilly’s Process Translation and Execution (PTE) team at the Lilly Medicine Foundry, a new advanced manufacturing and drug development center in Lebanon, Indiana. PTE translates API and drug substance process knowledge into clinical supply readiness, oversees technology transfer, and implements phase-appropriate control strategies to support right-first-time clinical manufacturing across multiple modalities. Under appropriate supervisory guidance, this role synthetically evaluates and facilitates the transfer of peptide upstream manufacturing processes from development laboratories to pilot plant operations, including kilo-scale and isolator production environments. The work supports early-phase cGMP manufacturing of gram-to-kilogram quantities of API for clinical trials. The scientist performs peptide chemistry and process familiarization, evaluates safety with safety and process engineering teams, documents laboratory trials and technical transfers, and contributes to process improvement and investigations. During the Medicine Foundry’s construction, project delivery, and startup phase (2025–2028), responsibilities may evolve as the organization, systems, business processes, and site culture are established. The initial work location is Lilly Technology Center in Indianapolis and/or Carmel, Indiana; the permanent location will be the Lilly Medicine Foundry in Lebanon, Indiana. Limited domestic and international travel of less than 5% may be required. The role requires working in manufacturing and laboratory environments.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level